Novel Immunocytokine IL12-SS1 (Fv) Inhibits Mesothelioma Tumor Growth in Nude Mice

A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface

(2013) Z. Tang et al.   MOLECULAR CANCER THERAPEUTICS

Mesothelin, a novel immunotherapy target for triple negative breast cancer

(2012) Julia Tchou et al.   BREAST CANCER RESEARCH AND TREATMENT

The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine Models of Cancer in Combination with Paclitaxel

(2012) N. Pasche et al.   CLINICAL CANCER RESEARCH

Mesothelin as a Potential Therapeutic Target in Human Cholangiocarcinoma

(2012) Liping Yu et al.   Journal of Cancer

In Vivo Imaging of Human Malignant Mesothelioma Grown Orthotopically in the Peritoneal Cavity of Nude Mice

(2012) Mingqian Feng et al.   Journal of Cancer

A novel high-affinity human monoclonal antibody to mesothelin

(2010) Mitchell Ho et al.   INTERNATIONAL JOURNAL OF CANCER

Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12

(2010) Roberto Sommavilla et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P

(2009) R. J. Kreitman et al.   CLINICAL CANCER RESEARCH

How are TH1 and TH2 effector cells made?

(2009) Derk Amsen et al.   CURRENT OPINION IN IMMUNOLOGY

A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity

(2009) Y. Feng et al.   MOLECULAR CANCER THERAPEUTICS

Mesothelin targeted cancer immunotherapy

(2007) Raffit Hassan et al.   EUROPEAN JOURNAL OF CANCER